Inovio Pharmaceuticals' Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses ...

BLUE BELL, Pa., May 16, 2012 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (INO) announced today that its SynCon® avian influenza vaccine generated protective HAI titers against six different ...

Inovio SynCon avian influenza vaccine demonstrates broad coverage

Inovio Pharmaceuticals, Inc. announced today that its SynCon avian influenza vaccine generated protective HAI titers against six different unmatched strains of H5N1 in a phase I clinical trial - a distinct clinical achievement on Inovio's path to develop universal influenza vaccines.

Vietnam Launches Project To Fight Avian Influenza

HANOI, May 21 (Bernama) - The Ministry of Agriculture and Rural Development (MARD) is to implement a project to prevent avian influenza funded by the US Agency for International Development (USAID), Vietnam news agency reported.

Mutant-flu paper published

Controversial study shows how dangerous forms of avian influenza could evolve in the wild.

Lab Security Standards Raise Chances of Mutant-Bird-Flu Catastrophe

Controversy over H5N1 avian influenza engineered into mammal-infecting form raises fears of flu research in bioterrorist hands, but a more pressing danger has been largely ignored: accidental releases, laboratory infections and disgruntled workers.